CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Tessier-Lavigne Marc Director | Grant or award | +165 | 2,434 | ||
| 2023-01-03 | Tessier-Lavigne Marc Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,929 | 1,929 | ||
| 2023-01-03 | Tessier-Lavigne Marc Director | Grant or award | +165 | 2,434 | ||
| 2023-01-03 | Tessier-Lavigne Marc Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,929 | 1,929 | ||
| 2023-01-03 | Zoghbi Huda Y Director | Grant or award | +165 | 1,247 | ||
| 2023-01-03 | Zoghbi Huda Y Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,929 | 1,929 | ||
| 2023-01-03 | COLES N ANTHONY Director | Grant or award | +165 | 1,258 | ||
| 2023-01-03 | COLES N ANTHONY Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,929 | 1,929 | ||
| 2023-01-03 | Thompson Craig B. Director | Grant or award | +40 | 319 | ||
| 2023-01-03 | Thompson Craig B. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +477 | 477 | ||
| 2022-12-28 | COLES N ANTHONY Director | Option exercise | +2,145 | $374.12 | $802K | 3,238 |
| 2022-12-28 | COLES N ANTHONY Director | Option exercise | +3,613 | $482.68 | $1.7M | 6,851 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −181 | $707.87 | $128K | 6,670 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −1 | $709.92 | $710 | 6,669 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −679 | $710.63 | $483K | 5,990 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −100 | $711.95 | $71K | 5,890 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −1,198 | $713.66 | $855K | 4,692 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −1,022 | $714.61 | $730K | 3,670 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −2,266 | $715.48 | $1.6M | 1,404 |
| 2022-12-28 | COLES N ANTHONY Director | Sale | −311 | $716.08 | $223K | 1,093 |
Page 61 of 105 · 2,088 trades